Combined inhibition of SHP2 overcomes adaptive resistance to type 1 BRAF inhibitors in BRAF V600E-driven high-grade glioma
Abiola Abdulrahman Ayanlaja, Michael Chang, Kriti Lalwani, Maria Ioannou, Jiawan Wang, Shreya Jagtap, Yanbo Yang, Calixto‐Hope G. Lucas, Jean M. Mulcahy Levy, Robyn D. Gartrell, Christine A. Pratilas, Karisa C. Schreck
This study shows that combining SHP2 inhibition with BRAF inhibitors overcomes resistance in BRAF V600E-driven gliomas by suppressing RAS/ERK signaling and preventing tumor growth.
Neuro-Oncology Advances · Jan 1, 2025Peer-reviewedCancer Biology